Famciclovir

Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection

Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis

Famciclovir in Multiple Sclerosis

Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection

Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes

Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster

Famvir for Treatment of Hearing in Unilateral Meniere's Disease

A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions

Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia